Rebecca Byam, Chief Financial Officer at HCW Biologics Inc. (HCWB), bought 15,000 shares at $2.58 ($39K) on 2022-09-14, disclosed to the SEC on 2022-09-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| HCWB | BUY | 2023-09-15 | $11K | — | Filing → |
| HCWB | BUY | 2023-09-13 | $21K | — | Filing → |
| HCWB | BUY | 2023-09-08 | $20K | — | Filing → |